Phaos Technology Holdings (Cayman) (POAS) Debt Ratio (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Debt Ratio of 0.08 for Q4 2025, up 20.28% on a QoQ basis from 0.07 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Debt Ratio (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Debt Ratio history runs 2 years deep, the most recent figure standing at 0.08 for Q4 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.08 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was 0.08 (changed N/A YoY) and the FY2025 annual result came in at 0.07, down 37.48% from the prior year.
Debt Ratio was 0.08 for Q4 2025 at Phaos Technology Holdings (Cayman), up from 0.07 in the prior quarter.
Across five years, Debt Ratio topped out at 0.11 in Q2 2024 and bottomed at 0.07 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	180.89 Bn	173.59 Bn	6.27 Bn	0.31
2	Stryker	127.82 Bn	124.94 Bn	3.81 Bn	0.32
3	Medtronic	107.49 Bn	98.27 Bn	6.41 Bn	0.30
4	Boston Scientific	67.24 Bn	65.78 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	48.02 Bn	44.34 Bn	1.29 Bn	0.04
6	Dexcom	28.25 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.17 Bn	25.89 Bn	1.98 Bn	0.27
8	Smith & Nephew	26.72 Bn	26.14 Bn	-	0.30
9	Koninklijke Philips	25.31 Bn	22.19 Bn	2.07 Bn	0.30
10	Phaos Technology Holdings (Cayman)	6.43 Mn	6.38 Mn	-	0.08

Download Data